0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Original Investigation | 
Desirée Valera-Gran, MHP; Manuela García de la Hera, MPH, PhD; Eva María Navarrete-Muñoz, MPH, PhD; et al.
JAMA Pediatr. 2014;168(11):e142611. doi:10.1001/jamapediatrics.2014.2611.

Original Investigation | 
L. Charles Bailey, MD, PhD; Christopher B. Forrest, MD, PhD; Peixin Zhang, PhD; et al.
JAMA Pediatr. 2014;168(11):1063-1069. doi:10.1001/jamapediatrics.2014.1539.

Original Investigation |  ONLINE FIRST
Adam J. Spanier, MD, PhD, MPH; Robert S. Kahn, MD, MPH; Allen R. Kunselman, MA; et al.
JAMA Pediatr. Published online October 06, 2014. doi:10.1001/jamapediatrics.2014.1397

Research Letter | 
Thomas Delate, PhD, MS; Yardlee S. Kauffman, PharmD, MPH; Sheila R. Botts, PharmD; et al.
JAMA Pediatr. 2014;168(7):679-681. doi:10.1001/jamapediatrics.2014.224.

Editorial | 
Miriam Cooper, MRCPsych, MSc; Kate Langley, PhD; Anita Thapar, FRCPsych, PhD
JAMA Pediatr. 2014;168(4):306-307. doi:10.1001/jamapediatrics.2013.5292.

Original Investigation | 
Zeyan Liew, MPH; Beate Ritz, MD, PhD; Cristina Rebordosa, MD, PhD; et al.
JAMA Pediatr. 2014;168(4):313-320. doi:10.1001/jamapediatrics.2013.4914.
Includes: Supplemental Content

JAMA Pediatrics Clinical Challenge | 
Ashika Odhav, MD; Chirag Odhav; Nimesh A. Dayal, MBBCh, MRCP, MSc
JAMA Pediatr. 2014;168(3):287-288. doi:10.1001/jamapediatrics.2013.3763.

Original Investigation | 
Melissa S. Stockwell, MD, MPH; Karen Broder, MD; Philip LaRussa, MD; et al.
JAMA Pediatr. 2014;168(3):211-219. doi:10.1001/jamapediatrics.2013.4469.
Includes: Supplemental Content

Review | 
Marian S. McDonagh, PharmD; Shelley Selph, MD; Alp Ozpinar, BS; et al.
JAMA Pediatr. 2014;168(2):178-184. doi:10.1001/jamapediatrics.2013.4200.
Includes: Supplemental Content

Special Feature |  FREE
JAMA Pediatr. 2013;167(2):186. doi:10.1001/jamapediatrics.2013.938b.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA Dermatology
Case Report/Case Series  | 
MEK Inhibitor–Induced Dusky Erythema:  Characteristic Drug Hypersensitivity Manifestation in 3 Patients
Urvi Patel, MD; Lynn Cornelius, MD; Milan J. Anadkat, MD
JAMA Dermatology
Original Investigation  | 
Cutaneous Adverse Effects Associated With the Tyrosine-Kinase Inhibitor Cabozantinib
Rena C. Zuo, BA; Andrea B. Apolo, MD; John J. DiGiovanna, MD; et al.
JAMA Neurology
Editorial  | 
Fingolimod and Risk of Varicella-Zoster Virus Infection:  Back to the Future With an Old Infection and a New Drug
Kenneth L. Tyler, MD
JAMA Neurology
Original Investigation  | 
Varicella-Zoster Virus Infections in Patients Treated With Fingolimod:  Risk Assessment and Consensus Recommendations for Management
Ann M. Arvin, MD; Jerry S. Wolinsky, MD; Ludwig Kappos, MD, PhD; et al.